Xiaobing Wang
24PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (24)
Sort by Publication Date:
|Mar 05, 2026
Development of Dihydroquinoxalinone-Based Dual CDK6/BET Inhibitors for Triple-Negative Breast Cancer Therapy.Long Zheng, Yiwei Zheng, Sijie Wu
|Jun 10, 2025
Design and Synthesis of PARP/CDK6 Dual-Target Inhibitors Modulating of Wnt/β-Catenin Signaling Pathway for the Treatment of BRCA Wild-Type TNBC.Yonglei Zhang, Fucheng Yin, Zhongwen Luo
|Jan 28, 2025
Correction to "Discovery of Dual CDK6/BRD4 Inhibitor Inducing Apoptosis and Increasing the Sensitivity of Ferroptosis in Triple-Negative Breast Cancer".Yonglei Zhang, Long Zheng, Liangliang Ma
|Nov 22, 2024
Discovery of Dual CDK6/BRD4 Inhibitor Inducing Apoptosis and Increasing the Sensitivity of Ferroptosis in Triple-Negative Breast Cancer.Yonglei Zhang, Long Zheng, Liangliang Ma
|Sep 19, 2024
Polypharmacological Drug Design Guided by Integrating Phenotypic and Restricted Fragment Docking Strategies.Shang Li, Xinxin Li, Liangliang Ma
|Aug 24, 2024
Discovery of Covalent MLKL PROTAC Degraders via Optimization of a Theophylline Derivative Ligand for Treating Necroptosis.Shang Li, Liangliang Ma, Xinxin Li
Pageof 4
